Fludarabine,Cyclophosphamide and Rituximab Followed by Zevalin for Non-Follicular Indolent Lymphomas. (Z0105)

This study has been terminated.
(Inability to recruit in time a sufficient number of patients)
Sponsor:
Collaborator:
Regional Hospital of Bolzano
Information provided by:
A.O. Ospedale Papa Giovanni XXIII
ClinicalTrials.gov Identifier:
NCT00354822
First received: July 19, 2006
Last updated: September 17, 2009
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: August 2009
  Estimated Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Publications: